Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

FDA ‘names and shames’ generic-blocking pharma companies

Celgene and Actelion top the list of offenders

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...

Six Degrees Medical Consulting

- PMLiVE

Janssen named ‘Pharma Company of the Year’ at business intelligence awards

Adelphi Research takes home ‘Agency of the year’ trophy

- PMLiVE

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s Brexit warning, Big data and prostate cancer

News from the frontline of pharma, biotech and healthcare

- PMLiVE

Immuno-oncology at ASCO: survival data, combinations and new indications

The abstracts reveal heaps of strong contenders in the NSCLC category

- PMLiVE

Pharma and biotech leaders back ’no deal’ Brexit warning

Ongoing division in Conservative party means 'no deal' remains a possibility

- PMLiVE

AstraZeneca and Emulate advance ‘organs-on-chips’ research partnership

Company advances partnership, aiming to integrate technology into full-scale R&D efforts

Lucid’s magic touch is recognised as they make the shortlist in five different categories for Communiqué 2018

Lucid has been working its magic with its clients again!Four of their pioneering programmes have been shortlisted as finalists for this year’s Communiqué awards. And they have been shortlisted for...

Lucid Group Communications Limited

- PMLiVE

Daily Brief:  Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame

A rapid round up of news from pharma, biotech and healthcare

- PMLiVE

Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer

Company has reached milestone in stem cell therapy as it looks to broaden range beyond diabetes

- PMLiVE

Novartis legal head resigns over Cohen payments

General counsel steps down, but Novartis still facing difficult questions

- PMLiVE

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

News from the frontline of healthcare, pharma and biotech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links